NanoEcho publishes investor letter

Read more about CEO Linda Persson and CTO Magnus Santesson as they tell more about their work to establish a strong company culture with a focus on delivery.

“It is essential that we ourselves are as driven as our staff, and that we maintain the same commitment that we want to see from them,” says Linda and Magnus.

You will also meet Professor and Chief Physician Henrik Thorlacius, senior medical advisor to NanoEcho, as he details how NanoEcho’s method may help rectal cancer patients in the future. 

Pågående emission
i NanoEcho

Erbjudande om att teckna aktier i NanoEcho AB (publ) i samband med IPO
Teckningstid: 29 maj – 28 juni

We use cookies to enhance your experience on our website and analyze our traffic. By clicking ‘Accept,’ you consent to our use of cookies. You can learn more about the types of cookies we use and how to manage them in our privacy policy.